SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules

Overview of attention for article published in Frontiers in Nephrology, January 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 30,131 followers.

RT @FrontNephrology: New Research: SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules https://t.co/1G…

RT @FrontNephrology: New Research: SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules https://t.co/1G…

RT @FrontNephrology: New Research: SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules https://t.co/1G…

Frontiers | SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules https://t.co/wpEVoqjOZk

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.